Adding to established science indicating that omega-3s have a role in reducing blood platelet aggregation, a new human trial published in the journal Nutrition, Metabolism, and Cardiovascular Diseases suggests that these effects are sex-specific.
Excessive platelet aggregation can cause to blood clotting, a major risk factor in diabetes, heart attacks, stroke, thrombosis, and other health conditions.
Australian academic researchers conducted a short-term blinded trial in which 15 males and 15 females were assigned to a single-dose capsule rich in eicosapentaenoic acid (EPA) docosahexaenoic acid (DHA) or placebo. Platelet aggregation was then measured at baseline, 2, 5, and 42 hours after supplementation.
Results of the trial indicate that EPA effectively reduced platelet aggregation in male subjects by an average of 11, 10.6, and 20.5% at each subsequent measurement after baseline; however, DHA was shown to be no more effective than placebo. Additionally, an inverse relationship between testosterone levels and platelet aggregation was observed with EPA.
As for the female subjects, only DHA reduced platelet aggregation (by 13.7% at 24 hours).
'Interactions between sex hormones and omega-3 fatty acids exist to differentially reduce platelet aggregation,'ÃÂ wrote the study...s author, concluding that 'For healthy individuals, males may benefit more from EPA supplementation while females are more responsive to DHA.'ÃÂ
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.